AI assistant
AMGEN INC — Director's Dealing 2022
Aug 12, 2022
29819_dirs_2022-08-12_7c1a7fcd-4362-4f54-9b4e-32994c21e735.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2022-08-10
Reporting Person: ECKERT ROBERT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-10 | Common Stock | M | 20000 | $85.59 | Acquired | 34575 | Direct |
| 2022-08-10 | Common Stock | F | 6791 | $252.09 | Disposed | 27784 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-10 | Nqso (Right to Buy) | $85.59 | M | 20000 | Disposed | 2023-01-28 | Common Stock (20000) | Direct |
Footnotes
F1: Non-market exercise of a total of 20,000 stock options expiring January 28, 2023 wherein 6,791 shares, in the aggregate, issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price with the remaining shares delivered to the reporting person.
F2: These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.